Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Zymergen (ZY) stock

Learn how to easily invest in Zymergen stock.

Zymergen Inc
NASDAQ: ZY - USD
CHEMICALS
$35.04
+$4.03 (+13.00%)

Zymergen Inc is a chemicals business based in the US. Zymergen shares (ZY) are listed on the NASDAQ and all prices are listed in US Dollars. Zymergen employs 754 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Zymergen

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ZY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Zymergen stock price (NASDAQ: ZY)

Use our graph to track the performance of ZY stocks over time.

Zymergen shares at a glance

Information last updated 2021-07-23.
52-week range$25.75 - $52.00
50-day moving average $39.90
200-day moving average $39.15
Wall St. target price$49.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Zymergen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Zymergen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Zymergen financials

Revenue TTM $14.1 million
Gross profit TTM $-162,386,000
Return on assets TTM -56.56%
Return on equity TTM -197.7%
Profit margin 0%
Book value N/A
Market capitalisation $4 billion

TTM: trailing 12 months

Shorting Zymergen shares

There are currently 2.0 million Zymergen shares held short by investors – that's known as Zymergen's "short interest". This figure is 44.7% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Zymergen shares can be evaluated.

Zymergen's "short interest ratio" (SIR)

Zymergen's "short interest ratio" (SIR) is the quantity of Zymergen shares currently shorted divided by the average quantity of Zymergen shares traded daily (recently around 433008.58369099). Zymergen's SIR currently stands at 4.66. In other words for every 100,000 Zymergen shares traded daily on the market, roughly 4660 shares are currently held short.

To gain some more context, you can compare Zymergen's short interest ratio against those of similar companies.

However Zymergen's short interest can also be evaluated against the total number of Zymergen shares, or, against the total number of tradable Zymergen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Zymergen's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Zymergen shares in existence, roughly 20 shares are currently held short) or 0.0406% of the tradable shares (for every 100,000 tradable Zymergen shares, roughly 41 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Zymergen.

Find out more about how you can short Zymergen stock.

Zymergen share dividends

We're not expecting Zymergen to pay a dividend over the next 12 months.

Zymergen overview

Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California. .

Frequently asked questions

What percentage of Zymergen is owned by insiders or institutions?
Currently 9.075% of Zymergen shares are held by insiders and 15.679% by institutions.
How many people work for Zymergen?
Latest data suggests 754 work at Zymergen.
When does the fiscal year end for Zymergen?
Zymergen's fiscal year ends in December.
Where is Zymergen based?
Zymergen's address is: 5980 Horton Street, EmeryVille, CA, United States, 94608

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site